M
Marjo E. E. van Kasteren
Researcher at Radboud University Nijmegen Medical Centre
Publications - 17
Citations - 884
Marjo E. E. van Kasteren is an academic researcher from Radboud University Nijmegen Medical Centre. The author has contributed to research in topics: Antibiotic prophylaxis & Surgical prophylaxis. The author has an hindex of 10, co-authored 14 publications receiving 752 citations.
Papers
More filters
Journal ArticleDOI
Antibiotic Prophylaxis and the Risk of Surgical Site Infections following Total Hip Arthroplasty: Timely Administration Is the Most Important Factor
Marjo E. E. van Kasteren,Judith Manniën,Alewijn Ott,Bart Jan Kullberg,Annette S. de Boer,Inge C. Gyssens +5 more
TL;DR: Intervention programs in search of amendable factors to prevent SSI should focus on timely administration of antibiotic prophylaxis, according to this study.
Journal ArticleDOI
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
L. Marije Hofstra,Nicolas Sauvageot,Jan Albert,Jan Albert,Ivailo Alexiev,Federico García,Daniel Struck,David A. M. C. van de Vijver,Birgitta Åsjö,Danail Beshkov,Suzie Coughlan,Diane Descamps,Algirdas Griskevicius,Osamah Hamouda,Andrzej Horban,Marjo E. E. van Kasteren,Tatjana Kolupajeva,Leondios G. Kostrikis,Kirsi Liitsola,Marek Linka,Orna Mor,Claus Nielsen,Dan Otelea,Dimitrios Paraskevis,Roger Paredes,Mario Poljak,Elisabeth Puchhammer-Stöckl,Anders Sönnerborg,Anders Sönnerborg,Danica Staneková,Maja Stanojevic,Kristel Van Laethem,Maurizio Zazzi,Snjezana Zidovec Lepej,Charles A. Boucher,Jean-Claude Schmit,Annemarie M. J. Wensing +36 more
TL;DR: The impact of baseline mutation patterns on susceptibility to antiretroviral drugs and the impact on baseline susceptibility is largest for nonnucleoside reverse transcriptase inhibitors.
Journal ArticleDOI
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy
Anne Boerekamps,Guido E.L. van den Berk,F. N. Lauw,Eliane M. S. Leyten,Marjo E. E. van Kasteren,Arne van Eeden,Dirk Posthouwer,Mark A. A. Claassen,Anton S M Dofferhoff,D. W. M. Verhagen,Wouter F W Bierman,Kamilla D. Lettinga,Frank P. Kroon,Corine E Delsing,Paul H. P. Groeneveld,Robert Soetekouw,Edgar J G Peters,Sebastiaan J. Hullegie,Stephanie Popping,David A. M. C. van de Vijver,Charles A. Boucher,Joop E. Arends,Bart J. A. Rijnders +22 more
TL;DR: Unrestricted DAA availability in the Netherlands was followed by a 51% decrease in acute HCV infections among HIV-positive MSM, which contradicts a decrease in risk behavior as an alternative explanation.
Journal ArticleDOI
Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis
Marjo E. E. van Kasteren,Judith Manniën,Bart Jan Kullberg,Annette S. de Boer,Nico J. D. Nagelkerke,Marja Ridderhof,Jan C. Wille,Inge C. Gyssens +7 more
TL;DR: The intervention led to improved quality of surgical prophylaxis and to reduced antibiotic use and costs without impairment of patient outcome.
Journal ArticleDOI
Improving the Process of Antibiotic Therapy in Daily Practice: Interventions to Optimize Timing, Dosage Adjustment to Renal Function, and Switch Therapy
Nils P. J. Vogtländer,Marjo E. E. van Kasteren,Stephanie Natsch,Bart Jan Kullberg,Yechiel A. Hekster,Jos W. M. van der Meer +5 more
TL;DR: Timing of antibiotic therapy and switch therapy may be improved with a combination of interventions to improve poor adjustment of dosing to renal function.